You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brentuximab vedotin

Showing 276 - 296 of 296
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma, Anaplastic Large-cell Lymphoma Trial in Belgium, Lithuania, Spain (brentuximab vedotin, Brentuximab vedotin

Completed
Has Results
  • Hodgkin Lymphoma
  • Anaplastic Large-cell Lymphoma
  • brentuximab vedotin
  • Brentuximab vedotin and rifampicin
  • Brussels, Belgium
  • +5 more
Mar 30, 2016

Anti-PD-1 and Chemotherapy for R/R Hodgkin Lymphoma

Completed
  • Hodgkin Lymphoma
  • Evaluate the improvement in response from the end of anti-PD-1 monotherapy
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud
Sep 7, 2018

Metastatic gpNMB Over-expressing Triple Negative Breast Cancer Trial in Worldwide (CDX-011, Capecitabine)

Completed
Has Results
  • Metastatic gpNMB Over-expressing Triple Negative Breast Cancer
  • Birmingham, Alabama
  • +139 more
Mar 6, 2019

Anaplastic Large Cell Lymphoma, Recurrent Childhood Anaplastic Large Cell Lymphoma Trial in Philadelphia (biological, drug,

Terminated
Has Results
  • Anaplastic Large Cell Lymphoma
  • Recurrent Childhood Anaplastic Large Cell Lymphoma
  • monoclonal antibody SGN-30
  • +8 more
  • Philadelphia, Pennsylvania
    Children's Oncology Group
Feb 14, 2018

Advanced Malignant Solid Tumor, Estrogen Receptor Negative, GPNMB Positive Trial (drug, biological, other)

Withdrawn
  • Advanced Malignant Solid Neoplasm
  • +17 more
  • Glembatumumab Vedotin
  • +4 more
  • (no location specified)
Jul 17, 2018

Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Anemia, Refractory, With Excess of Blasts Trial in United States (brentuximab

Completed
Has Results
  • Acute Lymphoid Leukemia
  • +3 more
  • brentuximab vedotin
  • Birmingham, Alabama
  • +28 more
Feb 5, 2016

Recurrent Adult Hodgkin Lymphoma Trial in New York (Brentuximab Vedotin, Laboratory Biomarker Analysis, Temsirolimus)

Completed
  • Recurrent Adult Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Nov 6, 2015

Metastatic gpNMB Expressing Triple Negative Breast Cancer Trial (glembatumumab vedotin)

No longer available
  • Metastatic gpNMB Expressing Triple Negative Breast Cancer
  • glembatumumab vedotin
  • (no location specified)
May 17, 2018

Triple Negative Breast Cancer Trial (Glembatumumab Vedotin)

Withdrawn
  • Triple Negative Breast Cancer
  • Glembatumumab Vedotin
  • (no location specified)
May 30, 2018

Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in Worldwide (Polatuzumab Vedotin, Rituximab)

Completed
  • Non-Hodgkins Lymphoma
  • Chronic Lymphocytic Leukemia
  • Stanford, California
  • +15 more
Jun 14, 2017

Disease, Hodgkin Trial in Canada, United States (brentuximab vedotin, doxorubicin, vinblastine)

Completed
  • Disease, Hodgkin
  • brentuximab vedotin
  • +4 more
  • Rochester, Minnesota
  • +3 more
Dec 17, 2014

Carcinomas, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic Trial in United States (brentuximab vedotin, rifampin, midazolam)

Completed
  • Carcinomas
  • +4 more
  • brentuximab vedotin
  • +3 more
  • Duarte, California
  • +5 more
Dec 17, 2014

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Germany, United States (brentuximab vedotin)

Completed
  • Disease, Hodgkin
  • +2 more
  • brentuximab vedotin
  • Birmingham, Alabama
  • +8 more
Dec 11, 2014

Hodgkin Lymphoma Trial in Bologna, Modena, Reggio Emilia (Brentuximab vedotin, ABVD)

Unknown status
  • Hodgkin Lymphoma
  • Brentuximab vedotin
  • ABVD
  • Bologna, Italy
  • +2 more
Oct 22, 2014

Lymphoma, Non-Hodgkin, Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic Trial in United States (SGN-35)

Completed
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +3 more
Dec 17, 2014

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in United States (SGN-35, gemcitabine)

Terminated
  • Disease, Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +4 more
Dec 17, 2014

Anaplastic Large-Cell Lymphoma Trial in United States (SGN-30 (anti-CD30 mAb))

Completed
  • Anaplastic Large-Cell Lymphoma
  • SGN-30 (anti-CD30 mAb)
  • Birmingham, Alabama
  • +17 more
Dec 17, 2014

Lymphoma Trial (brentuximab vedotin)

Withdrawn
  • Lymphoma
  • brentuximab vedotin
  • (no location specified)
Jul 24, 2013

GVHD Trial in Seattle (brentuximab vedotin, laboratory biomarker analysis, pharmacological study)

Withdrawn
  • Graft Versus Host Disease
  • brentuximab vedotin
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jun 25, 2013

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Completed
Has Results
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +4 more
  • monoclonal antibody SGN-30
  • +6 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Feb 10, 2015

Anaplastic Large Cell Lymphoma Trial in Houston (Cyclophosphamide, Doxorubicin HCl, vincristine sulfate)

Terminated
Has Results
  • Anaplastic Large Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
May 29, 2014